Literature DB >> 13439118

The properdin system and immunity. VII. Alterations in properdin levels and resistance to infection in mice following the administration of tissue polysaccharides.

L PILLEMER, M LANDY, M J SHEAR.   

Abstract

High molecular weight polysaccharide complexes derived from normal and neoplastic mammalian tissues were found to combine with properdin and to inactivate C'3 in vitro. These polysaccharide preparations were also found to alter properdin levels and non-specific resistance to Gram-negative infection in mice. In these manifestations, the tissue polysaccharides bore a marked resemblance to bacterial lipopolysaccharides. Some implications of the interactions of tissue polysaccharides and properdin in certain disease states are considered.

Entities:  

Keywords:  BACTERIA; IMMUNITY; POLYSACCHARIDES/effects; SERUM GLOBULIN

Mesh:

Substances:

Year:  1957        PMID: 13439118      PMCID: PMC2136727          DOI: 10.1084/jem.106.1.99

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  7 in total

1.  Serum properdin levels in hemorrhagic shock.

Authors:  E FRANK; J FINE; L PILLEMER
Journal:  Proc Soc Exp Biol Med       Date:  1955-06

2.  Stimulation of natural immunity to Escherichia coli infection: observations on mice.

Authors:  D ROWLEY
Journal:  Lancet       Date:  1955-01-29       Impact factor: 79.321

3.  Properdin system and immunity. II. Interaction of the properdin system with polysaccharides.

Authors:  L PILLEMER; M D SCHOENBERG; L BLUM; L WURZ
Journal:  Science       Date:  1955-09-23       Impact factor: 47.728

4.  The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena.

Authors:  L PILLEMER; L BLUM; I H LEPOW; O A ROSS; E W TODD; A C WARDLAW
Journal:  Science       Date:  1954-08-20       Impact factor: 47.728

5.  Increased resistance to infection and accompanying alteration in properidin levels following administration of bacterial lipopolysaccharides.

Authors:  M LANDY; L PILLEMER
Journal:  J Exp Med       Date:  1956-09-01       Impact factor: 14.307

6.  The properdin system and immunity. III. The zymosan assay of properdin.

Authors:  L PILLEMER; L BLUM; I H LEPOW; L WURZ; E W TODD
Journal:  J Exp Med       Date:  1956-01-01       Impact factor: 14.307

7.  Elevation of properdin levels in mice following administration of bacterial lipopolysaccharides.

Authors:  M LANDY; L PILLEMER
Journal:  J Exp Med       Date:  1956-06-01       Impact factor: 14.307

  7 in total
  12 in total

1.  Development of bactericidal properties against gram-negative organisms in the serum of young animals.

Authors:  J STERZL; J KOSTKA; A LANC
Journal:  Folia Microbiol (Praha)       Date:  1962-05       Impact factor: 2.099

2.  [Methodical and clinical research on the properdin system. II. Research on the behavior of the serum properdin and the C'3 components after gynecological operations].

Authors:  G SCHUMACHER; E EL HABASH; H D SCHLUMBERGER
Journal:  Arch Gynakol       Date:  1961

3.  [Methodical and clinical research on the properdin system. I. Methodical research on the simplified properdin test according to Isliker].

Authors:  G SCHUMACHER; F KNIERIM; H D SCHLUMBERGER
Journal:  Arch Gynakol       Date:  1961

4.  [The properdin problem].

Authors:  H E SCHULTZE; G SCHWICK
Journal:  Blut       Date:  1958-11

5.  Differential effect of hog gastric mucin on properdin and host resistance to infection.

Authors:  C W DEWITT
Journal:  J Bacteriol       Date:  1958-12       Impact factor: 3.490

6.  [Experimental contribution to the problem of inactivation of bacteriophages by the properdin system].

Authors:  K H HUSMANN
Journal:  Z Hyg Infektionskr       Date:  1959

7.  [Differences of stability of lipopolysaccharides from Proteus vulgaris OX 19 in serum and plasma].

Authors:  B SCHAR; F W KAHNT
Journal:  Experientia       Date:  1958-02-15

8.  [Properdin and hemolysis; heparin inhibition of erythrocyte hemolysis in patients with paroxysmal nocturnal hemoglobinuria].

Authors:  W FRITZSCHE; H MARTIN
Journal:  Klin Wochenschr       Date:  1957-12-01

9.  Pyrogenic material from normal erythrocytes.

Authors:  H MARTIN; W SPIELMANN
Journal:  Klin Wochenschr       Date:  1958-05-15

10.  Activator-specific requirement of properdin in the initiation and amplification of the alternative pathway complement.

Authors:  Yuko Kimura; Takashi Miwa; Lin Zhou; Wen-Chao Song
Journal:  Blood       Date:  2007-10-04       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.